Physiological effect of polyethylene glycol conjugation on stroma-free bovine hemoglobin in the conscious dog after partial exchange transfusion

Artificial Organs

Volumn 21, Issue 5, 1997, Pages 369-378

  Conover, Charles D ^a   Lejeune, Laura ^a   Shum, Kwok ^a   Gilbert, Cari ^a   Shorr, Robert G L ^a  

^a Enzon Incorporated   (United States)

Author keywords

blood chemistry; exchange transfusion; hemoglobin; hemoglobinuria; polyethylene glycol

Indexed keywords

BLOOD PRESSURE; DEXTRAN; HEMOGLOBIN; MAMMALS; POLYETHYLENES;

BEAGLE DOG; BLOOD CHEMISTRY; BOVINE HAEMOGLOBIN; EXCHANGE TRANSFUSION; HAEMOGLOBINS; HEART-RATE; HEMOGLOBINURIA; MEAN ARTERIAL PRESSURE; PHYSIOLOGICAL EFFECTS; TUBULARS;

POLYETHYLENE GLYCOLS;

DEXTRAN 70; HEMOGLOBIN; POLYETHYLENE GLYCOL HEMOGLOBIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DOG; FEMALE; HEART RATE; HEMOGLOBINURIA; MALE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; BOVINAE; CANIS FAMILIARIS;

EID: 0030949983     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1997.tb00733.x     Document Type: Article

References (48)

1. Savitsky J, Doczi J, Black J, Arnold J. A clinical safety trial of stroma-free hemoglobin. Clin Pharmacol Ther 1978;23(1): 73-80.
2. Malcolm D, Kissinger D, Garrioch M. Diaspirin cross-linked hemoglobin solution as a resuscitative fluid following severe hemorrhage in the rat. Biomater Artif Cells Immobilization Biotechnol 1992;20(2-4):495-7.
3. Lenz G, Junger H, Scheider M, Kothe N, Lissner R, Prince A. Elimination of pyridoxylated polyhemoglobin after partial exchange transfusion in chimpanzees. Biomater Artif Cells Immobilization Biotechnol 1991;19(4):699-708.
4. Chang T. Blood substitutes based on modified hemoglobin prepared by encapsulation or crosslinking: An overview. Biomater Artif Cells Immobilization Biotechnol 1992;20(2-4): 159-79.
5. Matsushita M, Yabuki A, Malchesky P, Harasaki H, Nosé Y. In vivo evaluation of a pyridoxalated-hemoglobin-polyoxyethylene conjugate. Biomater Artif Cells Artif Organs 1988;16(1):247-60.
6. Labrude P, Moulle P, Menu P, Vigeron C, Dellacherie E, Leonard M, Tayot J. Hemoglobin solutions coupled with polyethylene glycol 1900: Preparation, purification, quality control and pharmacologic trials by hemorrhagic shock. Int J Artif Organs 1988;11:393-402.
7. Iwashita Y, Iwasaki K, Ajisaka K, Ikeda K, Uematsu T. Use of a new oxygen carrying blood substitute. Proj Artif Organs 1983;2:867-70.
8. Matsushita M, Yabuki A, Chen J, Takahashi T, Harasaki H, Malchesky P, Iwashita, Y, Nosé Y. Renal effects of pyridoxalated-hemoglobin-polyoxyethylene conjugate solution as a blood substitute in exchange transfusion. Trans Am Soc Artif Intern Organs 1988;34:280-3.
9. Benesch R, Benesch R, Renthal R, Maeda N. Affinity labelling of the polyphosphate binding site of hemoglobin. Biochemistry 1972;11:3576-82.
10. Nho K, Zalipsky S, Abuchowski A, Davis F. PEG-modified hemoglobin as an oxygen carrier. Poly(ethylene glycol) chemistry: Biotechnical and biomedical application. New York: Plenum Press. 1992;171-82.
11. Nucci M, Shorr R, Abuchowski A. PEG-Hemoglobin. Drugs Future 1996;21(1):29-32.
12. Bradley R, Sloshberg S, Nho K, Czuba B, Shorr R. Production of PEG-modified bovine hemoglobin: Economics and feasibility. Artif Cells Blood Subst Immobilization Biotechnol 1994;22(3):657-67.
13. Nucci M, Shorr R, Abuchowski A. The therapeutic value of poly(ethylene glycol)-modified proteins. Adv Drug Delivery Rev 1993;6:133-51.
14. Hobbhahn J, Vogel H, Kothe N, Brendel W, Peter K, Jesch F. Hemodynamic and oxygen transport after partial and total blood exchange with pyridoxalated polyhemoglobin in dogs. Acta Anaesthesiol Scand 1985;29:537-43.
15. Vlahakes G, Lee R, Jacobs E, LaRaia P, Austen W. Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement. J Thorac Cardiovasc Surg 1990;100:379-88.
16. Nho K, Glower D, Bredehoeft S, Shankar H, Shorr R, Abuchowski A. PEG-bovine hemoglobin: Safety in a canine dehydrated hypovolemic-hemorrhagic shock model. Biomater Artif Cells Immobilization Biotechnol 1992;20(2-4):511-24.
17. Andersen M, Mouritzer C, Gabrielli E. Mechanisms of plasma hemoglobin clearance and selective deposition in the liver and kidney: Serum haptoglobin levels and selective deposition in the liver and kidney. Ann Surg 1966;64:905-12.
18. Muruganadam S, Chandrasekaran D, Shorr G. Effect of antioxidant on stability of polyethylene glycol modified bovine hemoglobin (PEG-Hb). Experimental biology 93/FASEB. 1994:3709.
19. Nho K, Linberg R, Johnson M, Gilbert C, Shorr R. PEG-hemoglobin: An efficient oxygen-delivery system in the rat exchange transfusion and hypovolemic shock models. Artif Cells Blood Subst Immobilization Biotechnol 1994;22(3): 795-803.
20. Moss G, DeWoskin R, Rosen A, Levine H, Palani C. Transport of oxygen and carbon dioxide by hemoglobin-saline solution in the red cell-free primate. Surg Gynecol Obstet 1976; 142:357-62.
21. Ning J, Peterson L, Anderson P, Biro G. Systemic hemodynamic and renal effects of unmodified human SFHS in dogs. Biomater Artif Cells Immobilization Biotechnol 1992;20(2-4): 723-7.
22. White C, Murray A, Greene J, Smith D, Medina F, Makovec G, Martin E, Bolin R. Toxicity of human hemoglobin solution infused into rabbits. J Lab Clin Med 1986;108:121-31.
23. Vogel W, Dennis R, Cassidy G, Apstein C, Valeri C. Coronary constrictor effect of stroma-free hemoglobin solutions. Am J Physiol 1986;251:H413-20.
24. Hess J, Macdonald V, Gomez C, Coppes V. Increased vascular resistance with hemoglobin-based oxygen carriers. Artif Cells Blood Subst Immobilization Biotechnol 1994; 22(3):361-72.
25. Stone A, Stein T, LaFortune J, Wise L. Renal vascular effects of stroma and stroma-free hemoglobin. Surg Gynecol Obstet 1979;149:874-6.
26. Lenz G, Junger H, Van den Ende R, Brotman B, Prince A. Hemodynamic effects after partial exchange transfusion with pyridoxylated polyhemoglobin in chimpanzees. Biomater Artif Cells Immobilization Biotechnol 1991;19(4):709-18.
27. Sharma A, Gulati A. Effect of diaspirin cross-linked hemoglobin and norepinephrine on systemic hemodynamics and regional circulation in rats. J Lab Clin Med 1994;123:299-308.
28. Bilello K, Schultz S, Powell C, Jaffin J, Cole F, Malcolm D. Diaspirin crosslinked hemoglobin (DCLHb™): Control of pressor effect with anti-hypertensive agents. Artif Cells Blood Subst Immobilization Biotechnol 1994;22(3):819-25.
29. Hamilton I, Schultz S, Cole F, Burhop K, Malcolm D. Characterization of diaspirin cross-linked hemoglobin's pressor response. Crit Care Med 1992;20:S106.
30. Krieter H, Hagan G, Kohler A, Rudolf B, Wenneis B, Bruckner U, Van Ackern K. Effects of a stroma-free polymerized bovine hemoglobin solution on oxygen transport, global and regional blood flow in a canine model of stepwise hemodilution. Anaesth Analg 1994;78:5226.
31. Wellum G, Irvine T, Zervas N. Dose responses of cerebral arteries of the dog, rabbit, and man to human hemoglobin in vitro. J Neurosurg 1980;53:486-90.
32. Feola M, Somoni J, Fishman D, Tran R, Canizaro P. Biocompatibility of hemoglobin solutions. I. Reactions of vascular endothelial cells to pure and impure hemoglobins. Artif Organs 1989;13(3):209-15.
33. Kilbourn R, Joly G, Cashon B, DeAngelo J, Bonaventura B. Cell-free hemoglobin reverses the endotoxin-mediated hyporesponsivity of rat aortic rings to a- adrenergic agents. Biochem Biophys Res Commun 1994;199(1):155-62.
34. Busse R, Trogish G, Bassenge E. The role of endothelium in the control of vascular tone. Basic Res Cardiol 1985;80: 475-90.
35. MacDonald V, Motterlini R. Vasoconstrictor effects in isolated rabbit heart perfused with bis(3,5-dibromosalicyl) fumarate cross-linked hemoglobin (ααHb). Artif Cells Blood Subst Immobilization Biotechnol 1994;22(3):565-75.
36. Martin W, Villani G, Jothianandian D, Furchgott R. Selective blockage of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and methylene blue in the rabbit aorta. J Pharmacol Exp Ther 1985;232:708-12.
37. Furchgott R, Martin W, Cherry, P. Blockage of endothelium-dependent vasodilation by hemoglobin: a possible factor in vasospasm associated with hemorrhage. Adv Prostaglandin Thromboxane Leukotriene Res 1986;15:499-502.
38. Bleeker W, Van der Plas J, Feitsma R, Agterberg J, Rigter G, DeVries-van Rossen A, Pauwels E, Bakker J. In vivo distribution and elimination of hemoglobin modified by intramolecular cross-linking with 2-nor-2-formylpyridoxal5′-phosphate. J Lab Clin Med 1989;113:151-61.
39. Moss G, Gould S, Rosen A, Sehgal L, Sehgal H. Animal model for nephrotoxicity of haemoglobin tetramer. Lancet 1986;1:1219.
40. Kosara H, Uozumi M, Tyuma I. The interaction between nitrogen oxides and hemoglobin and endothelium-derived relaxing factor. Free Radical Biol Med 1989;7:653-8.
41. Jia L, Bonaventura C, Bonaventura J, Stamler J. S-nitrosohaemoglobin: A dynamic activity of blood involved in vascular control. Nature 1996;380:221-6.
42. Bunn H, Esham W, Bull R. The renal handling of hemoglobin. I. Glomerular filtration. J Exp Med 1969;129:909-24.
43. Anderson P, Ning J, Biro G. Clearance of differentially labelled infused hemoglobin and polymerized hemoglobin from dog plasma and accumulation in urine and selected tissues. Biomater Artif Cells Immobilization Biotechnol 1992;20(2-4): 781-7.
44. Gilbert C, Nho K, Johnson M, Linberg R, Shorr R. Hemoglobinuria in rats: A sensitive test of renal filtering and absorption of PEG-hemoglobin, a red blood cell substitute. Artif Cells Blood Subst Immobilization Biotechnol 1994;22(3): 535-41.
45. Loeb W. The dog. In: Loeb WF, Quimby FW, eds. The clinical chemistry of laboratory animals. Elmsford, NY: Pergamon Press, 1988;321-43.
46. Conover C, Malatesta P, Lejeune L, Chang C, Shorr R. The effects of polyethylene glycol conjugated bovine hemoglobin (PEG-Hb) in a conscious porcine model. J Invest Med 1996; 44:238-46.
47. Maunsbach A, Madden S, Latta H. Light and electron microscopic changes in proximal tubules of rats after administration of glucose, mannitol, sucrose or dextran. Lab Invest 1962;11: 421-32.
48. Christensen E, Maunsbach A. Effects of dextran on lysosomal ultrastructure and protein digestion in renal proximal tubule. Kidney Int 1979;16:310-1.